Cleared Special

K183265 - Selectra Catheters

K183265 is the FDA 510(k) clearance for Selectra Catheters by Biotronik, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 20-day FDA review.

K183265 · Biotronik, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
20d
Days
Class 2
Risk

K183265 is an FDA 510(k) clearance for the Selectra Catheters, Selectra Accessory Kit. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Biotronik, Inc. (Lake Oswego, US). The FDA issued a Cleared decision on December 13, 2018 after a review of 20 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Biotronik, Inc. devices

Submission Details

510(k) Number K183265 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 23, 2018
Decision Date December 13, 2018
Days to Decision 20 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
105d faster than avg
Panel avg: 125d · This submission: 20d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K183265.
ViperCath XC Peripheral Exchange Catheter
K183000 · Cardiovascular Systems, Inc. · Dec 2018
ASAHI Corsair Pro XS
K182420 · Asahi Intecc Co., Ltd. · Dec 2018
Xcess Guiding Catheter
K180797 · Curatia Medical Co. · Dec 2018
Route 92 Medical Delivery Catheter
K182512 · Route 92 Medical, Inc. · Dec 2018
Tractus Crossing Support Catheter
K180889 · Tractus Vascular, LLC · Dec 2018
React 71 Catheter
K182097 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Nov 2018